S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
DilutionScan read 21 of AVENUE THERAPEUTICS, INC.'s SEC filings and found 5 warrant series, 1 convertible, 1 ATM program, 4 shelf registrations and 3 S-1 registrations on file for ATXI. The latest dilution event on file is ATM sales on Dec 31, 2025. Analysis updated Nov 4, 2026.
Raise routes on file: effective shelf + pending S-1 · latest dilution event 308 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Dec 31, 2025 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Proposed maximum
Shares registered
Issued 2021
Proposed maximum
Shares registered
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2024
Total capacity
Sold to date
Issued 2021
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z